Penserra Capital Management’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,379
Closed -$5K 1363
2022
Q2
$5K Sell
3,379
-1,320
-28% -$1.95K ﹤0.01% 1354
2022
Q1
$23K Sell
4,699
-1,353
-22% -$6.62K ﹤0.01% 1229
2021
Q4
$37K Buy
+6,052
New +$37K ﹤0.01% 1102